VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BRK-ABerkshire Hathaway Inc.
$746597.94$377.6B
Overview & Verdict
OverviewShould I Buy?
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksBRK-AFinancials

Berkshire Hathaway Inc. (BRK-A) Financials

30Y historyFree accessUpdated daily

Revenue growth remains stagnant at 4.4% in 2026Q1, though underwriting discipline persists as evidenced by a 87.0% combined ratio.

BRK-A Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue375.39B371.44B371.43B364.48B302.02B276.09B245.51B257.24B245.86B244.36B223.78B209.85B194.17B179.54B160.5B143.15B137.9B112.49B116.42B118.33B97.6B82.51B72.78B63.51B42.02B38.59B34.4B23.9B13.62B10.43B10.54B
Revenue Growth %1.11%0%1.91%20.68%9.39%12.46%-4.56%4.63%0.62%9.2%6.64%8.08%8.15%11.86%12.12%3.81%22.58%-3.37%-1.62%21.24%18.3%13.36%14.6%51.15%8.87%12.19%43.91%75.5%30.58%-1.02%187.54%
Medical Costs & Claims285.55B283.67B284.86B293.54B242.63B220.93B196.73B156.48B151.69B158.85B133.9B118.97B110.46B102.3B91.65B145.39B78.13B125.48B76.94B75.89B57.1B55.4B55.42B40.66B27.23B28.73B30.72B16.58B7.06B7.79B7.13B
Medical Cost Ratio %76.07%76.37%76.69%80.54%80.33%80.02%80.13%60.83%61.7%65.01%59.84%56.69%56.89%56.98%57.1%101.56%56.65%111.55%66.09%64.13%58.51%67.15%76.14%64.03%64.8%74.43%89.3%69.38%51.82%74.73%67.7%
Gross Profit89.84B87.78B86.58B70.95B59.39B55.16B48.78B100.75B94.17B85.5B89.87B90.88B83.71B77.24B68.85B-2.23B59.77B-12.99B39.48B42.45B40.5B27.1B17.37B22.84B14.79B9.87B3.68B7.32B6.56B2.64B3.4B
Gross Margin %23.93%23.63%23.31%19.46%19.67%19.98%19.87%39.17%38.3%34.99%40.16%43.31%43.11%43.02%42.9%-1.56%43.35%-11.55%33.91%35.87%41.49%32.85%23.86%35.97%35.2%25.57%10.7%30.62%48.18%25.27%32.3%
Gross Profit Growth %-1.38%22.03%19.45%7.67%13.08%-51.58%6.99%10.14%-4.86%-1.11%8.57%8.37%12.18%3184.86%-103.73%560.17%-132.9%-6.99%4.81%49.43%56.05%-23.97%54.47%49.87%168.23%-49.74%11.55%148.93%-22.55%871.11%
Operating Expenses32.47B28.89B27.14B22.82B17.81B20.14B18.81B-765M88.01B64.68B57.31B55.81B55.58B48.45B46.62B-17.55B40.72B-24.54B31.91B22.29B23.72B14.83B6.67B11.25B8.79B8.43B-1.84B4.87B2.25B-190.9M-302.2M
OpEx / Revenue %8.65%7.78%7.31%6.26%5.9%7.3%7.66%-0.3%35.79%26.47%25.61%26.6%28.62%26.98%29.05%-12.26%29.53%-21.82%27.41%18.83%24.3%17.98%9.16%17.72%20.92%21.84%-5.35%20.37%16.51%-1.83%-2.87%
Depreciation & Amortization13.72B13.48B12.86B12.49B10.9B10.72B10.6B10.06B9.78B9.19B8.9B7.78B7.37B6.51B6.15B5.49B4.28B3.13B2.81B2.41B2.07B982M941M849M679M945M997M688M265M227M151.6M
Combined Ratio %84.72%84.15%84%86.8%86.23%87.32%87.79%60.53%97.49%91.48%85.45%83.29%85.51%83.96%86.15%89.3%86.18%89.73%93.49%82.96%82.81%85.13%85.3%81.75%85.72%96.27%83.95%89.75%68.33%72.9%64.83%
Operating Income57.38B58.88B59.44B48.12B41.59B35.02B29.98B101.52B6.17B20.82B32.56B35.07B28.13B28.8B22.24B15.31B19.05B11.55B7.57B20.16B16.78B12.27B10.7B11.59B6B1.44B5.52B2.45B4.31B2.83B3.71B
Operating Margin %15.28%15.85%16%13.2%13.77%12.68%12.21%39.47%2.51%8.52%14.55%16.71%14.49%16.04%13.85%10.7%13.82%10.27%6.51%17.04%17.19%14.87%14.7%18.25%14.28%3.73%16.05%10.25%31.67%27.1%35.17%
Operating Income Growth %--0.94%23.51%15.72%18.75%16.83%-70.47%1545.91%-70.38%-36.04%-7.16%24.66%-2.31%29.5%45.2%-19.62%64.92%52.52%-62.43%20.16%36.76%14.66%-7.7%93.18%317.25%-73.95%125.35%-43.21%52.6%-23.72%30.24%
EBITDA71.1B72.36B72.29B60.61B52.49B45.74B40.57B111.58B15.95B30.01B41.46B42.85B35.5B35.3B28.39B20.81B23.33B14.68B10.38B22.57B18.84B13.25B11.64B12.44B6.68B2.38B6.52B3.14B4.58B3.05B3.86B
EBITDA Margin %18.94%19.48%19.46%16.63%17.38%16.57%16.53%43.38%6.49%12.28%18.53%20.42%18.28%19.66%17.69%14.53%16.92%13.05%8.92%19.07%19.31%16.06%15.99%19.59%15.9%6.17%18.95%13.13%33.62%29.28%36.61%
Interest Expense4.18B5.07B5.2B5B4.35B4.17B4.08B3.96B3.85B4.39B3.74B3.52B3.25B2.8B2.74B2.66B2.56B1.99B1.96B1.91B1.72B723M721M472M725M968M916M134M109M112M99.7M
Non-Operating Income0000000-5.14B-1.69B-7.4B-4.85B-3.39B-3.23B-2.8B-2.74B-2.66B-2.56B-1.99B-1.96B-1.91B-1.72B-1.25B-958M-901M-1.08B-968M-982M-134M-109M-112M-99.7M
Pretax Income89.63B82.46B110.38B120.17B-30.5B111.86B55.69B102.7B4B23.84B33.67B34.95B28.11B28.8B22.24B15.31B19.05B11.55B7.57B20.16B16.78B12.79B10.94B12.02B6.36B1.44B5.59B2.45B4.31B2.83B3.71B
Pretax Margin %23.88%22.2%29.72%32.97%-10.1%40.52%22.68%39.92%1.63%9.76%15.04%16.65%14.47%16.04%13.85%10.7%13.82%10.27%6.51%17.04%17.19%15.5%15.03%18.93%15.13%3.73%16.24%10.25%31.67%27.1%35.17%
Income Tax16.86B15.2B20.82B23.02B-8.5B20.91B12.44B20.9B-321M-21.52B9.24B10.53B7.93B8.95B6.92B4.57B5.61B3.54B1.98B6.59B5.5B4.16B3.57B3.81B2.06B590M2.02B852M1.46B898M1.2B
Effective Tax Rate %18.81%18.43%18.86%19.16%27.88%18.69%22.34%20.36%-8.02%-90.26%27.45%30.14%28.23%31.08%31.14%29.83%29.43%30.63%26.12%32.71%32.81%32.52%32.64%31.66%32.38%41.03%36.12%34.78%33.77%31.77%32.29%
Net Income72.47B66.97B89B96.22B-22.76B89.94B42.52B81.42B4.02B44.94B24.07B24.08B19.87B19.48B14.82B10.25B12.97B8.05B4.99B13.21B11.02B8.53B7.31B8.15B4.29B795M3.33B1.56B2.83B1.9B2.49B
Net Margin %19.31%18.03%23.96%26.4%-7.54%32.57%17.32%31.65%1.64%18.39%10.76%11.48%10.23%10.85%9.24%7.16%9.4%7.16%4.29%11.17%11.29%10.34%10.04%12.83%10.2%2.06%9.67%6.51%20.78%18.23%23.62%
Net Income Growth %-10.41%-24.75%-7.51%522.79%-125.31%111.51%-47.77%1924.79%-91.05%86.67%-0.04%21.19%2.03%31.38%44.57%-20.92%60.98%61.29%-62.2%19.95%29.16%16.69%-10.34%90.18%439.12%-76.11%113.74%-44.98%48.87%-23.61%213.07%
EPS (Diluted)33.6031.0441.2744.27-10.3639.6417.7849830.002445.0027330.0014640.0014655.0012090.0011850.008970.006210.007935.005190.003225.008550.007140.005535.004755.005310.002790.000.012190.001020.002265.001545.002070.00
EPS Growth %-10.47%-24.79%-6.78%527.32%-126.14%122.95%-99.96%1938.04%-91.05%86.68%-0.1%21.22%2.03%32.11%44.44%-21.74%52.89%60.93%-62.28%19.75%29%16.4%-10.45%90.32%--100%114.71%-54.97%46.6%-25.36%206.67%
EPS (Basic)-31.0441.2744.27-10.3639.6417.7849830.002445.0027330.0014640.0014655.0012090.0011850.008970.006210.007935.005190.003225.008550.007140.005535.004755.005310.002790.000.012190.001020.002265.001545.002070.00
Diluted Shares Outstanding2.16B2.16B2.16B2.17B2.2B2.27B2.39B1.63M1.64M1.65M1.64M1.64M1.64M1.64M1.65M1.65M1.64M1.55M1.55M1.55M1.54M1.54M1.54M1.53M1.53M1.53M1.52M1.52M1.25M1.23M1.21M

Key Metrics

Growth RegimeMixed
ProfitabilityStrong
Balance SheetFortress
Cash FlowRobust
Top Statement Risk

Capital Deployment Size Drag

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Stagnant Top-Line Revenue Trends

As reported in recent financial filings, Berkshire Hathaway's quarterly revenue growth has fluctuated significantly, with the most recent 2026Q1 figure of 4.4% following a period of inconsistent performance, suggesting that the conglomerate's massive scale may be limiting its ability to achieve sustained, high-single-digit organic expansion.

The lack of consistent revenue momentum across the last ten quarters indicates that the firm's diverse industrial and retail subsidiaries are struggling to outpace broader economic headwinds. Investors should monitor whether this stagnation reflects a deliberate shift toward capital preservation or an inability to find meaningful growth opportunities within the current interest rate environment.

Underwriting Discipline Drives Profitability

Based on the provided income statement data, the company maintained a combined ratio of 87.0% in 2026Q1, demonstrating that the insurance segment continues to generate significant underwriting profit despite the inherent volatility of global catastrophic loss events that periodically impact the broader insurance industry.

The consistent ability to keep the combined ratio well below the 100% threshold suggests that the firm's decentralized underwriting model remains highly effective at pricing risk. This underwriting margin provides a stable foundation for the firm's broader capital recycling strategy, effectively insulating the bottom line from the cyclicality of its non-insurance industrial segments.

Volatility Masking Core Operational Health

According to the historical income statement data, net income has experienced extreme swings, such as the $30.8B reported in 2025Q3 compared to $4.6B in 2025Q1, which appears to be primarily driven by accounting requirements for unrealized investment gains rather than underlying operational performance shifts.

The divergence between operating income and net income highlights the necessity of focusing on core underwriting and subsidiary performance rather than headline earnings. Analysts should interpret these fluctuations as a byproduct of the firm's equity portfolio accounting, which may obscure the actual health of the underlying insurance and industrial businesses.

Size Drag and Capital Deployment

Based on the recent accumulation of cash and equivalents, the firm appears to be facing a structural challenge in deploying capital, as evidenced by the lack of significant revenue growth and the increasing difficulty of finding acquisitions that can move the needle for a company of this magnitude.

The current cash position warrants further investigation into whether the firm is entering a defensive posture due to a lack of attractive market opportunities. This potential 'size drag' suggests that future returns may be increasingly constrained by the sheer volume of capital that must be deployed to achieve meaningful growth.

BRK-A — Frequently Asked Questions

Quick answers to the most common questions about buying BRK-A stock.

What was Berkshire Hathaway Inc.'s (BRK-A) revenue in 2025?

For fiscal year 2025, Berkshire Hathaway Inc. (BRK-A) reported total revenue of $371.44B. This represents a 3424.8% increase compared to $10.54B in 1996.

Is Berkshire Hathaway Inc. (BRK-A) profitable?

Berkshire Hathaway Inc. (BRK-A) is profitable, generating $66.97B in net income for the fiscal year ending 2025 with a net profit margin of 18.0%.

What is Berkshire Hathaway Inc.'s operating profit margin?

Berkshire Hathaway Inc. (BRK-A) reported an operating income of $58.88B, resulting in an operating profit margin of 15.9%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Berkshire Hathaway Inc.'s gross profit and gross margin?

Berkshire Hathaway Inc. (BRK-A) generated $87.78B in gross profit for the year, representing a gross profit margin of 23.6%. This demonstrates the company's core pricing power and production efficiency.